Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival
Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival
复制标题
DOI:
10.1200/jco.2001.19.2.577
复制
发表时间:
2001-01-15
影响因子:
45.3
通讯作者:
Reinhold, U
中科院分区:
文献类型:
--
作者:
Ugurel, S;Rappl, G;Reinhold, U
Purpose: To determine the predictive value of the angiogenic serum factors angiogenin, vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and interleukin-8 (IL-8) for the prognosis of patients with malignant melanoma.Patients and Methods: Angiogenin,VEGF, bFGF,and IL-8 were measured in sera of 125 melanoma patients with different stages of disease and with or without current therapy including interferon alfa and different cytostatics in comparison with 30 healthy controls using enzyme-linked immunosorbent assay.Results: Serum levels of angiogenin, VEGF, bFGF, and IL-8 were significantly increased in melanoma patients compared with healthy controls. Elevated serum concentrations of VEGF, bFGF, and IL-8 were associated with advanced disease stages and tumor burden. Cytostatic therapy of patients was accompanied by increased serum levels of angiogenin, bFGF, and IL-8. As shown by univariate analysis, elevated serum levels of VEGF (P =.0001 and .0036), bFGF (P